LTR Pharma Ltd

LTP

Company Profile

  • Business description

    LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.

  • Contact

    9A/204 Alice Street
    BrisbaneQLD4000
    AUS

    T: +61 1800519711

    https://www.ltrpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

Stocks News & Analysis

stocks

Microsoft earnings: Strong, including Azure, but overall guidance is in line

We think Microsoft stock is moderately undervalued.
stocks

After earnings, is Tesla stock a buy, a sell, or fairly valued?

Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.
stocks

3 cheap fully franked stocks

Well priced Aussie shares that offer a tax rebate.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,230.1023.400.25%
CAC 408,157.2943.59-0.53%
DAX 4024,118.895.32-0.02%
Dow JONES (US)47,522.12109.88-0.23%
FTSE 1009,760.063.920.04%
HKSE26,282.6963.45-0.24%
NASDAQ23,581.14377.33-1.57%
Nikkei 22552,199.36873.751.70%
NZX 50 Index13,529.2869.990.52%
S&P 5006,822.3468.25-0.99%
S&P/ASX 2008,933.2020.000.22%
SSE Composite Index3,986.860.04-0.00%

Market Movers